Heaney, Liam G ;
Busby, John ;
Hanratty, Catherine E...
Heaney , L G , Busby , J , Hanratty , C E , Djukanovic , R , Woodcock , A , Walker , S M , Hardman , T C , Arron , J R , Choy , D F , Bradding , P , Brightling , C E , Chaudhuri , R , Cowan , D C , Mansur , A H , Fowler , S J , Niven , R M , Howarth , P H , Lordan , J L , Menzies-Gow , A , Harrison , T W , Robinson , D S , Holweg , C T J , Matthews , J G & Pavord , I D 2020 , ' Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial ' , The Lancet Respiratory Medicine , vol. 9 , no. 1 , pp. 57-68 . https://doi.org/10.1016/S2213-2600(20)30397-0.
,
2020
